by bureau Peppr | 14 September, 2021 | Testimonials
ResoTher Pharma ResoTher Pharma ApS is truly amazed by the BioConnection’s team’s commitment to our Fill&Finish project. Especially during some serious setbacks, the BioConnection team has been extremely dedicated in assisting us even when it was outside their...
by bureau Peppr | 28 June, 2021 | News
Oss, The Netherlands, June 28, 2021. BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale filling line BioConnection B.V., an independent CMO (Contract Manufacturing...
by bureau Peppr | 26 April, 2021 | Campaigns
BioConnection ensures your clinical and commercial supply line for steriles, even in pandemic times Have you experienced the worldwide GMP manufacturing capacity for sterile injectables being very limited due to the high demand for Covid-19 treatments and vaccines? Do...
by bureau Peppr | 10 February, 2021 | News
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and...
by bureau Peppr | 23 December, 2020 | News
BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine in its state-of-the-art-GMP manufacturing facility in the Netherlands. AdaptVac aims to accelerate the development of safe and efficacious...